Tutorials
Humacyte Inc logo

Humacyte Inc

$ 4.40 +0.91 (+26.07%) 11:08 PM EST
P/E:
At Loss
P/B:
4.37
Market Cap:
$ 453.22M
Enterprise V:
$ 204.35M
Volume:
3.36M
Avg Vol (2M):
390.05K
Volume:
3.36M
Market Cap $:
453.22M
PE Ratio:
At Loss
Avg Vol (2-Month):
390.05K
Enterprise Value $:
204.35M
PB Ratio:
4.37
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Humacyte Inc
NAICS : 325412 SIC : 2834
2525 East North Carolina Highway 54, Durham, NC, USA, 27713
Description
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions.
Name Current Vs Industry Vs History
Cash-To-Debt 4.04
Equity-to-Asset 0.39
Debt-to-Equity 0.49
Debt-to-EBITDA -73.82
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 92.04
9-Day RSI 82.94
14-Day RSI 71.95
6-1 Month Momentum % -38.09

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 19.45
Quick Ratio 19.45
Cash Ratio 19.16

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-08-12)

HUMA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:HUMA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.5
Beta 0
Volatility % 0
14-Day RSI 71.95
14-Day ATR ($) 0.270085
20-Day SMA ($) 3.50625
12-1 Month Momentum % 0
52-Week Range ($) 3.07 - 17.45
Shares Outstanding (Mil) 103

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Humacyte Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More